Fox Jonathan C 4
4 · Edgewise Therapeutics, Inc. · Filed Oct 2, 2025
Insider Transaction Report
Form 4
Fox Jonathan C
Director
Transactions
- Award
Common Stock
2025-10-01+728→ 13,002 total
Footnotes (1)
- [F1]Consists of restricted stock units, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. (the "Issuer") common stock, granted and released to the reporting person on October 1, 2025, as a Quarterly Retainer Award pursuant to Section 2.4 of the Issuer's Outside Director Compensation Policy, as amended.